DJ Inovio Pharmaceuticals Inc. Stock Underperforms Thursday When Compared To Competitors
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Inovio Pharmaceuticals Inc. $(INO)$ slipped 1.46% to $5.41 Thursday, on what proved to be an all-around dismal trading session for the stock market, with the NASDAQ Composite Index falling 0.05% to 18,282.05 and Dow Jones Industrial Average falling 0.14% to 42,454.12.
This was the stock's second consecutive day of losses.
Inovio Pharmaceuticals Inc. closed $9.34 short of its 52-week high ($14.75), which the company achieved on April 1st.
The stock demonstrated a mixed performance when compared to some of its competitors Thursday, as Johnson & Johnson $(JNJ)$ fell 0.09% to $160.51, Statera Biopharma Inc. (STAB) remained unchanged, and Pfizer Inc. $(PFE)$ fell 2.82% to $29.34.
Data source: Dow Jones Market Data, FactSet. Data compiled October 10, 2024.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
October 10, 2024 17:28 ET (21:28 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.